Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2020
Cash flows from operating activities:
Net income	$ 1,138,243	$ 660,870	$ 221,384
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	127,507	113,398	98,933
Amortization of intangibles	156,946	117,183	97,234
Amortization of debt issuance costs	11,322	15,407	10,743
Impairment charges	0	0	10,057
Deferred income tax benefit	(51,885)	(9,026)	(11,212)
(Gain) loss on disposition of property, plant and equipment	(7,564)	1,136	3,990
Stock-based compensation expense	31,421	30,514	19,889
Changes in assets and liabilities:
Accounts receivable	39,247	(234,693)	(115,232)
Inventories	(381,543)	(538,756)	133,290
Prepaid income taxes, expenses and other	(13,747)	(32,717)	18,427
Accounts payable	(116,608)	229,173	60,469
Accrued liabilities and other	78,385	123,078	(14,059)
Long-term liabilities and other	(21,471)	50,915	7,028
Net cash provided by operating activities	990,253	526,482	540,941
Cash flows from investing activities:
Purchases of property, plant and equipment	(242,357)	(128,835)	(106,697)
Proceeds from dispositions of property, plant and equipment	16,067	1,950	27,677
Business acquisitions, net of cash acquired	(781,967)	(310,938)	0
Other	(41,000)	9,330	(5,229)
Net cash used in investing activities	(1,049,257)	(428,493)	(84,249)
Cash flows from financing activities:
Borrowings on revolving asset-based credit facilities	660,088	225,676	379,222
Payments on revolving asset-based credit facilities	(559,035)	(224,836)	(379,986)
Proceeds from issuance of senior unsecured notes	500,000	0	0
Payments on term-loan credit facilities	(332,907)	(59,700)	(274,963)
Payments on other debt	(11,535)	(13,950)	(14,493)
Payments of debt issuance costs	(8,445)	0	0
Cash dividends paid	(94,944)	(90,801)	(88,318)
Payments on finance lease obligations	(1,084)	(749)	(442)
Purchase of treasury shares	(165,107)	0	0
Payments related to vesting of stock-based awards	(18,011)	(8,317)	(3,763)
Other	(16,861)	(15,761)	(10,173)
Net cash used in financing activities	(47,841)	(188,438)	(392,916)
Effect of exchange rate changes on cash and cash equivalents and restricted cash	(30,171)	(2,208)	26,325
Net increase (decrease) in cash and cash equivalents and restricted cash	(137,016)	(92,657)	90,101
Cash and cash equivalents and restricted cash, beginning of period	448,706	541,363	451,262
Cash and cash equivalents and restricted cash, end of period	311,690	448,706	541,363
Cash and cash equivalents and restricted cash, total	311,690	448,706	541,363
Less: restricted cash	137	2,854	2,844
Cash and cash equivalents, end of period	311,553	445,852	538,519
Supplemental cash flow information:
Income taxes paid	380,874	226,527	56,803
Interest paid	74,455	78,865	101,784
Non-cash investing and financing transactions:
Capital expenditures in accounts payable	$ 4,733	$ 6,304	$ 3,458